Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Conditions: Adenoid Cystic Carcinoma; Metastatic Adenoid Cystic Carcinoma; Recurrent Adenoid Cystic Carcinoma Interventions: Drug: REM-422 Sponsors: Remix Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials